(R)-GNE-140 – (2003234-63-5)

Vorasidenib, 1644545-52-7, AG-881, Vorasidenib (AG-881), Vorasidenib [INN], AG881, Vorasidenib [USAN], Voranigo, 789Q85GA8P, Vorasidenib (AG881), 6-(6-chloropyridin-2-yl)-N2, N4-bis((R)-1, 1, 1-trifluoropropan-2-yl)-1, 3, 5-triazine-2, 4-diamine, 6-(6-chloropyridin-2-yl)-2-N, 4-N-bis[(2R)-1, 1, 1-trifluoropropan-2-yl]-1, 3, 5-triazine-2, 4-diamine, VORASIDENIB [WHO-DD], AG 881 [WHO-DD], 6-(6-chloropyridin-2-yl)-N2, N4-bis[(2R)-1, 1, 1-trifluoropropan-2-yl]-1, 3, 5-triazine-2, 4-diamine, 1, 3, 5-Triazine-2, 4-diamine, 6-(6-chloro-2-pyridinyl)-N2, N4-bis((1R)-2, 2, 2-trifluoro-1-methylethyl)-, 1, 3, 5-Triazine-2, 4-diamine, 6-(6-chloro-2-pyridinyl)-N2, N4-bis[(1R)-2, 2, 2-trifluoro-1-methylethyl]-, vorasidenibum, 6-(6-chloropyridin-2-yl)-2-N, 4-N-bis((2R)-1, 1, 1-trifluoropropan-2-yl)-1, 3, 5-triazine-2, 4-diamine, 9UO, AG 881, AG-881 Vorasidenib, Vorasidenib (USAN/INN), Vorasidenib [USAN:INN], UNII-789Q85GA8P, CHEMBL4279047, SCHEMBL16393139, SCHEMBL22396621, SCHEMBL23573057, GTPL10663, BDBM279948, EX-A2574, UQC54552, NSC803600, s8611, US10028961, Compound 101, WHO 10525, AKOS037648888, CCG-268824, CS-8033, NSC-803600, AC-36152, BS-15954, DA-59042, HY-104042, C73178, D11834, 6-(6-Chloro-2-pyridinyl)-N, N'-bis((2R)-1, 1, 1-trifluoro-2-propanyl)-1, 3, 5-triazine-2, 4-diamine, 6-(6-Chloro-2-pyridinyl)-N2, N4-bis[(1R)-2, 2, 2-trifluoro-1-methylethyl]-1, 3, 5-triazine-2, 4-diamine, 6-(6-chloropyridin-2-yl)-N~2~, N~4~-bis[(2R)-1, 1, 1-trifluoropropan-2-yl]-1, 3, 5-triazine-2, 4-diamine, 6-(6-chloropyridin-2-yl)-N2, N4-bis((R)-1, 1, 1-trifluoro propan-2-yl)-1, 3, 5-triazine-2, 4-diamine